Tuesday, February 18, 2025

A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes

New research shows sotagliflozin is the only drug in its class to demonstrate these results.

from Top Health News -- ScienceDaily https://ift.tt/RxP8ynb
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Sleep apnea’s hidden heart disease trigger found in the gut

A surprising gut-heart connection may help explain why sleep apnea increases the risk of cardiovascular disease. In mice, disabling a bile a...